Week51, 2023
1. Influenza activity is elevated and increasing across most parts of the U.S., with 16.1% of respiratory specimens testing positive for influenza.
2. Among clinical lab samples, 81.4% were Influenza A and 18.6% Influenza B. Public health labs identified 85.5% Influenza A and 14.5% Influenza B.
3. Of subtyped Influenza A viruses, 79.0% were A(H1N1)pdm09 and 21.0% were A(H3N2).
4. Outpatient visits for influenza-like illness (ILI) accounted for 6.1% of all visits, above the national baseline for the 8th consecutive week.
5. Cumulative hospitalization rate reached 15.4 per 100,000 population, with 14,732 new flu-associated hospitalizations reported this week.
6. Influenza-related deaths represented 0.5% of total deaths, and six pediatric deaths occurred this week, bringing the seasonal total to 20.
7. CDC estimates 7.1 million illnesses, 73,000 hospitalizations, and 4,500 deaths from influenza so far in the 2023-24 season.
8. Vaccination is ongoing, and individuals aged 6 months and older are urged to get vaccinated amidst active virus spread; antiviral treatments are available.
9. Multiple respiratory viruses, including influenza, COVID-19, and RSV, are co-circulating, contributing to ILI trends and regional variability in activity.
10. Flu activity is expected to continue rising, with regions reporting very high ILI activity increasing from 10 to 14 jurisdictions compared to last week.